Form 4: LENSAR Director Aimee Weisner Receives RSU Grant
Statement of Changes in Beneficial Ownership
Director Aimee Weisner was granted 17,421 restricted stock units as part of LENSAR, Inc.'s annual non-employee director compensation program.
Summary
- Director Aimee Weisner acquired 17,421 restricted stock units (RSUs) on June 3, 2026.
- Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock.
- The grant is part of the company's standard non-employee director compensation program.
- Following this transaction, the reporting person's total beneficial ownership is 110,368 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized compensation practice consistent with corporate governance best practices.
Negatives
- None identified.
Risks
- Vesting is subject to continued service through June 3, 2027.
- Settlement of RSUs is contingent upon specific events such as termination, change in control, death, or disability.
Future Outlook
The RSUs are scheduled to vest in full on June 3, 2027, provided the director remains in service to the company.
Management Comments
- The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.
Industry Context
StockSavvy.ai notes that equity-based compensation for board members is a standard industry practice in the medical device sector to ensure long-term alignment between leadership and shareholder value.
Comparison to Industry Standards
- The grant of RSUs as part of annual director compensation is consistent with standard corporate governance practices for small-cap medical technology companies.
- The vesting period of one year is typical for annual director equity awards.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensation event.
Next Steps
- Vesting of the RSUs on June 3, 2027.
Key Dates
| Date | Description |
|---|---|
| 06/03/2026 | Date of RSU grant transaction. |
| 06/05/2026 | Date of filing. |
| 06/03/2027 | Vesting date for the granted RSUs. |
Keywords
LENSAR, LNSR, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.